Your browser doesn't support javascript.
loading
Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists.
Nagler, M; Angelillo-Scherrer, A; Méan, M; Limacher, A; Abbal, C; Righini, M; Beer, J H; Osterwalder, J; Frauchiger, B; Aschwanden, M; Matter, C M; Kucher, N; Cornuz, J; Banyai, M; Husmann, M; Staub, D; Mazzolai, L; Hugli, O; Rodondi, N; Aujesky, D.
Afiliação
  • Nagler M; Department of Haematology and Central Haematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Angelillo-Scherrer A; Department of Clinical Research, University of Bern, Bern, Switzerland.
  • Méan M; Department of Haematology and Central Haematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Limacher A; Department of Clinical Research, University of Bern, Bern, Switzerland.
  • Abbal C; Department of General Internal Medicine, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Righini M; Division of General Internal Medicine, Lausanne University Hospital, Lausanne, Switzerland.
  • Beer JH; CTU Bern, and Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
  • Osterwalder J; Division of Hematology, Lausanne University Hospital, Lausanne, Switzerland.
  • Frauchiger B; Division of Angiology and Hemostasis, Geneva University Hospital, Geneva, Switzerland.
  • Aschwanden M; Cantonal Hospital of Baden, Baden, Switzerland.
  • Matter CM; Emergency Department, Cantonal Hospital of St Gallen, St Gallen, Switzerland.
  • Kucher N; Department of Internal Medicine, Cantonal Hospital of Frauenfeld, Frauenfeld, Switzerland.
  • Cornuz J; Division of Angiology, Basel University Hospital, Basel, Switzerland.
  • Banyai M; Center for Molecular Cardiology, University of Zurich and University Heart Center, University Hospital Zurich, Zurich, Switzerland.
  • Husmann M; Division of Angiology, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Staub D; Department of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, Switzerland.
  • Mazzolai L; Division of Angiology, Cantonal Hospital of Lucerne, Lucerne, Switzerland.
  • Hugli O; Division of Angiology, Zurich University Hospital and University of Zurich, Zurich, Switzerland.
  • Rodondi N; Division of Angiology, Basel University Hospital, Basel, Switzerland.
  • Aujesky D; Service of Angiology, Lausanne University Hospital, Lausanne, Switzerland.
J Thromb Haemost ; 15(11): 2165-2175, 2017 11.
Article em En | MEDLINE | ID: mdl-28834238
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vitamina K / Coagulação Sanguínea / Tromboembolia Venosa / Vitamina K Epóxido Redutases / Citocromo P-450 CYP2C9 / Variantes Farmacogenômicos / Anticoagulantes Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: J Thromb Haemost Assunto da revista: HEMATOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vitamina K / Coagulação Sanguínea / Tromboembolia Venosa / Vitamina K Epóxido Redutases / Citocromo P-450 CYP2C9 / Variantes Farmacogenômicos / Anticoagulantes Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: J Thromb Haemost Assunto da revista: HEMATOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suíça